Precision Medicine Market Report 2026

The precision medicine market size has grown strongly in recent years. It will grow from $87.91 billion in 2025 to $96.27 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to advancements in genomic research, declining cost of gene sequencing, increasing prevalence of cancer and genetic disorders, growth in biopharmaceutical R&D spending, regulatory approvals for targeted therapies.

The precision medicine market size is expected to see strong growth in the next few years. It will grow to $137.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of next-generation sequencing adoption, rising demand for personalized treatment plans, growing use of ai-driven drug discovery, increasing investments in precision diagnostics, integration of digital health platforms. Major trends in the forecast period include rising adoption of companion diagnostics, shift toward personalized oncology therapies, integration of multi-omics data in clinical decision-making, expansion of precision medicine in rare and genetic diseases, increasing collaboration between pharma and diagnostic firms.

The rising prevalence of cancer is expected to propel the growth of the precision medicine market. Cancer remains one of the leading causes of death globally, with approximately one in five individuals developing the disease during their lifetime. Precision medicine in oncology involves analyzing tumor DNA to identify mutations or other genetic abnormalities driving cancer progression. This allows physicians to select therapies tailored to the unique genetic profile of a patient’s tumor, improving treatment efficacy and outcomes. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency, over 35 million new cancer cases are projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is driving demand for precision medicine solutions.

Major companies in the precision medicine market are emphasizing technological innovations, such as data ingestion platforms, to enhance access to public datasets and streamline analytics. Data ingestion refers to the process of collecting and importing data from multiple sources into a centralized storage or processing system. For example, in May 2023, Google Cloud, a US-based software development company, launched two AI-powered solutions designed to accelerate drug discovery and precision medicine initiatives. These tools enable researchers to interpret genomic data and identify protein structures more efficiently, improving drug development workflows, shortening time-to-market for critical therapies, and facilitating collaboration across research teams and multi-cloud environments.

In July 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Proteomics for an undisclosed amount. This acquisition expands Thermo Fisher’s capabilities in proteomics - the large-scale study of proteins - which plays a crucial role in precision medicine. Olink Proteomics, a Sweden-based biotechnology company, contributes innovative technologies and services focused on protein biomarker analysis, supporting targeted therapies and personalized treatment approaches.

Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica.

North America was the largest region in the precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the precision medicine market by increasing costs and supply chain complexities for gene sequencing instruments, diagnostic reagents, and bioinformatics hardware sourced globally. Higher import duties have particularly affected drug discovery, companion diagnostics, and gene sequencing segments, with Asia-Pacific and Europe experiencing notable impacts due to cross-border dependency on specialized components. Oncology and genomic testing applications face cost pressures that may slow adoption in price-sensitive healthcare systems. However, tariffs are also encouraging localized manufacturing, regional partnerships, and domestic innovation, supporting long-term supply resilience and technology self-sufficiency in key markets.

The precision medicine market research report is one of a series of new reports that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Precision medicine is a type of treatment that prevents, detects, or manages disease by using information about an individual’s genes or proteins. It takes into account a person’s genetics, environment, and lifestyle to select the therapy most likely to be effective.

The main technologies used in precision medicine include bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics applies computational tools to organize, analyze, interpret, visualize, and store data related to biological macromolecules. Precision medicine is applied in areas such as oncology, respiratory diseases, central nervous system disorders, immunology, genetic diseases, and more, and is implemented across sectors including pharmaceuticals, diagnostic companies, healthcare providers, and IT firms.

The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.